Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.09 |
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.09 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.09 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |